Bosh sahifaLGND • NASDAQ
add
Ligand Pharmaceuticals Inc
107,14 $
Seans yopilganidan keyin:(0,00%)0,00
107,14 $
Yopilgan:26-iyl, 16:01:54 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
106,01 $
Kunlik diapazon
105,75 $ - 108,42 $
Yillik diapazon
49,24 $ - 108,91 $
Bozor kapitalizatsiyasi
1,92 mlrd USD
Oʻrtacha hajm
129,56 ming
Narx/foyda
20,47
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 30,98 mln | -29,56% |
Joriy xarajat | 19,14 mln | -1,33% |
Sof foyda | 86,14 mln | 105,34% |
Sof foyda marjasi | 278,06 | 191,53% |
Har bir ulushga tushum | 1,20 | -47,37% |
EBITDA | 11,75 mln | -49,61% |
Amaldagi soliq stavkasi | 24,07% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 310,59 mln | 9,88% |
Jami aktivlari | 913,87 mln | 12,67% |
Jami passivlari | 107,35 mln | -34,85% |
Umumiy kapital | 806,52 mln | — |
Tarqatilgan aksiyalar | 17,96 mln | — |
Narxi/balansdagi bahosi | 2,36 | — |
Aktivlardan daromad | 0,88% | — |
Kapitaldan daromad | 0,98% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 86,14 mln | 105,34% |
Operatsiyalardan naqd pul | 18,73 mln | -44,82% |
Sarmoyadan naqd pul | -3,78 mln | -135,79% |
Moliyadan naqd pul | 12,18 mln | 1 671,87% |
Naqd pulning sof oʻzgarishi | 27,14 mln | -37,93% |
Boʻsh pul | 27,58 mln | -2,01% |
Haqida
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.
The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud.
In 2018 its CEO was listed among the top five highest paid CEOs in San Diego. Wikipedia
Tashkil etilgan
sen 1987
Sayt
Xodimlar soni
58
